EHJ Dialogues
EHJ Dialogues is a webinar series taking place on the last Thursday of every month. This series aims to provide a forum for discussion of key topics within the cardiology research arena. The live, online-only format allows moderated interaction between speakers and audience members globally. At a time when physical interaction is restricted, EHJ Dialogues will bring our community together and allow us to share and discuss key research.
All EHJ Dialogues will take place via Zoom and will be live-streamed to the ESC YouTube channel. Attendees interested in actively participating during the event will be able to comment in the YouTube chat (which will require logging in with a Google account).
Visit the ESC YouTube Channel today
Upcoming Events
EHJ Dialogue with Prof. Ulrich Sigwart on the past, present, and future of stentingThursday, 24 April 2025
|
EHJ Dialogues Archive
27-Feb-2025
In this EHJ Dialogue, leading researcher in cardiovascular science and Editor-in-Chief of Cardiovascular Research (CVR) Prof. Tomasz Guzik shares his expertise on the role of inflammation in hypertension, discusses the challenges AI presents for scientific publishing, and offers a preview of key innovations at the upcoming ESC Congress in Madrid. Additionally, he highlights his humanitarian work supporting cardiovascular health initiatives in Africa.
30-Jan-2025
In this EHJ Dialogue, Prof. Jane Somerville, a pioneer in congenital heart disease management, shares insights from her groundbreaking career. With congenital heart disease now affecting more adults than children, Prof. Somerville’s contributions have shaped the field and improved care for countless patients.
26-Dec-2024
In this special year-end EHJ Dialogue, EHJ editors and guests come together to discuss the most impactful advancements in cardiovascular medicine, as highlighted by the top EHJ papers of 2024.
28-Nov-2024
In this EHJ Dialogue, Prof. Luigi Fontana explores the transformative potential of targeted lifestyle interventions in modulating key metabolic and molecular pathways that influence aging and disease progression. This discussion extends beyond the cardiovascular system, highlighting how common chronic diseases across different organs and systems share a unified metabolic and molecular foundation, often shaped by unhealthy lifestyle choices.
31-Oct-2024
In this EHJ Dialogue, Weekly Journal Scan Editor Prof. Carlo Patrono and Editor-in-Chief Prof. Filippo Crea are joined by Prof. Jonathan Piccini, Prof. Bianca Rocca, and Prof. Hugo ten Cate to discuss where field of oral anticoagulation is going after Asundexian failed in atrial fibrillation.
26-Sep-2024
Weekly Journal Scan Editor Prof. Carlo Patrono takes us through the fascinating history, present applications, and future potential of aspirin in cardiovascular care.
25-Jul-2024
Weekly Journal Scan Editor Prof. Carlo Patrono takes us through the fascinating history, present applications, and future potential of aspirin in cardiovascular care.
27-Jun-2024
In this EHJ Dialogue, Prof. Rory Collins shares insights from his extensive career in trials, meta-analyses, and epidemiology.
30-May-2024
In this EHJ Dialogue, Prof. Deepak Bhatt shares his life story and explores the complexities and challenges in interpreting clinical trial data.
25-Apr-2024
In this EHJ Dialogue, Nobel Laureate Prof. Lou Ignarro takes us on a fascinating journey from his early curiosity as a ten-year-old student to the pinnacle of scientific achievement: receiving the Nobel Prize.
25-Jan-2024
In this EHJ Dialogue, Prof. William McKenna delves into the captivating history of cardiomyopathies, tracing its remarkable journey from the pioneering days of ECG to the cutting-edge advances in genetic diagnostics.
28-Dec-2023
In this EHJ Dialogue, editors Lina Badimon, Anne Tybjærg-Hansen, Cecilia Linde, Lale Tokgözoglu, and Teresa Lopez Fernandez join Editor-in-Chief Prof. Filippo Crea to look back and discuss the most impactful EHJ papers of 2023. Together, they discuss key breakthroughs, emerging trends, and the studies that have shaped cardiovascular research over the past year.
30-Nov-2023
In this EHJ Dialogue, Weekly Journal Scan Editors Prof. Carlo Patrono and Prof. Massimo Volpe are joined by Prof. Stefanie Dimmeler and Prof. Thomas Thum to discuss RNA therapeutics in cardiovascular disease.
28-Sep-2023
In this EHJ Dialogue, renowned heart failure expert Prof. Bertram Pitt discusses the past, present, and future of mineralocorticoid receptor antagonists, exploring key clinical trial outcomes and emerging therapeutic strategies.
27-Jul-2023
In this EHJ Dialogue, Prof. Paul Ridker explores the role of inflammation in atherosclerosis, tracing the evolution from C-reactive protein (CRP) as a biomarker to the identification of therapeutic targets.
25-May-2023
In this EHJ Dialogue, Prof. Eva Prescott highlights the vital role of women in cardiology and explores the challenges faced in developing impactful clinical Guidelines.
27-Apr-2023
In this EHJ Dialogue, leading expert in COVID-19-related cardiovascular disease, Dr. Ziyad Al-Aly examines Long COVID that currently affects millions worldwide. He discusses the emerging challenges for cardiologists in managing the wave of COVID-19–related cardiovascular conditions and outlines the long-term implications for patient care and healthcare systems.
30-Mar-2023
In this EHJ Dialogue, Prof. Peter Schwartz shares his unique insights into the evolution of long QT syndrome, his pivotal role in its discovery, and the emerging promise of precision medicine for channelopathies.
28-Mar-2024
In this EHJ Dialogue, Weekly Journal Scan Editors Prof. Giovanna Liuzzo and Prof. Carlo Patrono are joined by Prof. A. Michael Lincoff, Prof. W. Timothy Garvey, and Prof. Geltrude Mingrone to discuss obesity and cardiovascular risk.
23-Feb-2023
In this EHJ Dialogue, Prof. Josep Brugada recounts the pivotal events that led to the discovery of Brugada syndrome and explores the challenges and future perspectives in managing this life-threatening condition.
26-Jan-2023
In this EHJ Dialogue, Prof. Javed Butler focuses on SGLT2 in heart failure
29-Dec-2022
In this EHJ Dialogue, editors Lina Badimon, Anne Tybjærg-Hansen, Cecilia Linde, and Lale Tokgözoglu join Editor-in-Chief Prof. Filippo Crea to look back and discuss the most impactful EHJ papers of 2022. Together, they discuss key breakthroughs, emerging trends, and the studies that have shaped cardiovascular research over the past year.
24-Nov-2022
In this EHJ Dialogue, Prof. Göran Hanssen explores the history of atherosclerosis, tracing key discoveries and advancements that have shaped our understanding of the disease.
27-Oct-2022
In this EHJ Dialogue, Prof. Valentin Fuster discusses the SECURE trial, presented at the ESC Congress 2022 and published in the New England Journal of Medicine, highlighting its key findings and clinical implications.
29-Sep-2022
In this EHJ Dialogue, Prof. Gregory Lip discusses the ABC approach to the management of atrial fibrillation, outlining its key principles and clinical applications.
28-Jul-2022
In this EHJ Dialogue, Prof. George Bakris, Prof. Ernesto Schiffrin, and Prof. Francesco Paneni discuss therapeutic developments in the management of diabetic chronic kidney disease.
30-Jun-2022
In this EHJ Dialogue, echocardiography pioneer Prof. Anthony DeMaria shares his remarkable journey in the field. He reflects on the inception of echocardiography, its evolution into a cornerstone of cardiovascular imaging, and the exciting prospects for its future.
26-May-2022
In this EHJ Dialogue, Prof. Karen Sliwa shares her remarkable scientific journey studying heart failure and discusses cardiovascular diseases in Africa, highlighting both the challenges and opportunities in the field.
29-Jul-2021
In this EHJ Dialogue, Prof. Silvia Priori explores the role of precision medicine in the prevention of sudden cardiac death, highlighting advances in genetic risk assessment, tailored interventions, and emerging therapeutic strategies.
28-Apr-2022
In this EHJ Dialogue, Prof. Kazem Rahimi discusses blood pressure reduction, which has been viewed as a key factor for reducing cardiovascular disease burden in hypertension. Recent analyses from the Blood Pressure Lowering Treatment Trialists’ (BPLTT) Collaboration have highlighted the beneficial effects of blood pressure lowering irrespective of blood pressure levels, age and CV risk profile, thus independently from a diagnosis of hypertension.
24-Feb-2022
In this EHJ Dialogue, Prof. Bernard Gersh discusses his life's journey from Zambia to Rochester USA via South Africa, reflecting on the experiences and influences that have shaped his career in cardiology.
27-Jan-2022
In this EHJ Dialogue, Prof. Marc Pfeffer delves into the PARADISE-MI trial, summarizing its major findings and sharing his personal perspectives on the study results.
30-Dec-2021
In this special EHJ Dialogue organized one year after the editorial handover, past Editor-in-Chief Prof. Thomas F. Lüscher and current Editor-in-Chief Prof. Filippo Crea reflect on the past year. They discuss key developments in cardiovascular research, the evolution of the European Heart Journal, and the transition of leadership, offering insights into the journal’s future direction and continued commitment to excellence in publishing.
25-Nov-2021
In this EHJ Dialogue, Prof. Faiez Zannad discusses the challenges and pitfalls in the interpretation of clinical trials.
28-Oct-2021
In this EHJ Dialogue, Prof. Roxana Mehran explores the critical issues surrounding cardiovascular disease in women, highlighting both the challenges and emerging opportunities for enhanced care. With a focus on specific insights in diagnosis, treatment, and research, she offers expert perspectives aimed at advancing the field of women’s cardiovascular health.
24-Jun-2021
In this EHJ Dialogue, Prof. Colin Baigent discusses individual randomised trials, meta-analyses, and treatment Guidelines.
27-May-2021
In this EHJ Dialogue, Prof. Ferid Murad discusses the groundbreaking discovery of nitric oxide as a signaling molecule and shares his journey to the Nobel Prize. He reflects on the impact of his research, its clinical implications, and the future of nitric oxide-based therapies in cardiovascular medicine.
29-Apr-2021
In this EHJ Dialogue, Prof. Barbara Casadei reflects on the role and future of scientific societies in the aftermath of COVID-19, discussing the challenges, adaptations, and opportunities that have emerged from the pandemic.
25-Mar-2021
In this EHJ Dialogue, Prof. A. John Camm explores the latest advancements in the understanding and management of arrhythmias, discussing key developments in diagnosis, risk stratification, and treatment strategies.
25-Feb-2021
In this EHJ Dialogue, Prof. Christopher Cannon discusses his recent publication on the VERTIS trial, highlighting its key findings and implications for cardiovascular and renal outcomes in patients with diabetes. Joining the discussion is Prof. John Jarcho, Deputy Editor of the New England Journal of Medicine, who provides additional insights into the study’s impact on clinical practice and future research.
28-Jan-2021
In this EHJ Dialogue, Prof. Patrick Serruys reflects on his distinguished career in interventional cardiology, tracing the evolution of the field from pioneering device design to clinical breakthroughs. He shares key insights from decades of research, technological advancements, and the impact of innovation on patient care.
29-Dec-2020
In this EHJ Dialogue, Prof. Valentin Fuster navigates the full spectrum of cardiovascular science, from molecular mechanisms to health promotion, offering the perspective of a protagonist.
26-Nov-2020
In this EHJ Dialogue, Prof. Salim Yusuf explores epidemiology and prevention, offering a bold and thought-provoking global perspective.
29-Oct-2020
In this EHJ Dialogue, Prof. Milton Packer explores the landscape of heart failure, from its underlying mechanisms to cutting-edge treatments, offering insights into what the future may hold.
24-Sep-2020
In this EHJ Dialogue, Prof. Eugene Braunwald reflects on the 400-year journey of cardiology, exploring its evolution and milestones.
